4//SEC Filing
IDEXX LABORATORIES INC /DE 4
Accession 0001140361-16-087991
$IDXXCIK 0000874716operating
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 7:33 PM ET
Size
9.0 KB
Accession
0001140361-16-087991
Insider Transaction Report
Form 4
CRAIG THOMAS
Director
Transactions
- Exercise/Conversion
Common Stock
2016-11-23$26.66/sh+9,924$264,524→ 32,783 total - Sale
Common Stock
2016-11-23$120.06/sh−8,500$1,020,519→ 24,283 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2016-11-23−9,924→ 0 totalExercise: $26.66Exp: 2017-02-13→ Common Stock (9,924 underlying)
Footnotes (3)
- [F1]Represents the weighted average sales price of the shares sold ranging from a low of $119.5082 to a high of $120.23 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F2]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,962 shares on February 14, 2011, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split").? The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F3]Not applicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000874716
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 7:33 PM ET
- Size
- 9.0 KB